![Gerd Maass](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gerd Maass
Directeur Général chez Siloanlagen Achberg Holding GmbH
Postes actifs de Gerd Maass
Sociétés | Poste | Début | Fin |
---|---|---|---|
Siloanlagen Achberg Holding GmbH
![]() Siloanlagen Achberg Holding GmbH Financial ConglomeratesFinance Siloanlagen Achberg Holding GmbH is an investment holding private company. The company is based in Achberg, Germany. The CEO of the German company is Gerd Maass. | Directeur Général | - | - |
ETHRIS GmbH
![]() ETHRIS GmbH Miscellaneous Commercial ServicesCommercial Services ETHRIS GmbH is a German company that specializes in developing innovative therapies and vaccines using its proprietary messenger RNA technology platform. The company is based in Planegg, Germany. The company is a leader in delivering stabilized mRNA directly to the respiratory system via optimized formulation and nebulization technologies. ETHRIS is rapidly advancing its pipeline of immuno-modulation, protein replacement therapies, and differentiated vaccines, with the ultimate goal of improving patients' lives. The company was founded by Carsten Rudolph and Christian Plank, and Carsten Rudolph has been the CEO since incorporation. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Gerd Maass
Statistiques
Internationale
Allemagne | 3 |
Opérationnelle
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Sectorielle
Finance | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Siloanlagen Achberg Holding GmbH
![]() Siloanlagen Achberg Holding GmbH Financial ConglomeratesFinance Siloanlagen Achberg Holding GmbH is an investment holding private company. The company is based in Achberg, Germany. The CEO of the German company is Gerd Maass. | Finance |
ETHRIS GmbH
![]() ETHRIS GmbH Miscellaneous Commercial ServicesCommercial Services ETHRIS GmbH is a German company that specializes in developing innovative therapies and vaccines using its proprietary messenger RNA technology platform. The company is based in Planegg, Germany. The company is a leader in delivering stabilized mRNA directly to the respiratory system via optimized formulation and nebulization technologies. ETHRIS is rapidly advancing its pipeline of immuno-modulation, protein replacement therapies, and differentiated vaccines, with the ultimate goal of improving patients' lives. The company was founded by Carsten Rudolph and Christian Plank, and Carsten Rudolph has been the CEO since incorporation. | Commercial Services |
- Bourse
- Insiders
- Gerd Maass
- Expérience